GleanMark

GAMIFANT Trademark

GAMIFANT is a USPTO trademark filed by SWEDISH ORPHAN BIOVITRUM AG. Status: Registered.

Trademark Facts

MarkGAMIFANT
Serial Number87283834
Registration Number5505933
StatusRegistered
Filing Date2016-12-29
Registration Date2018-07-03
Mark TypeWord
Nice Classes001 (Chemicals)
OwnerSWEDISH ORPHAN BIOVITRUM AG
Attorney of RecordBrendan J. Hughes
Prosecution Events38
Latest EventCHAN on 2023-10-18

Goods & Services

Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes | Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes

Related